7/22/2024Innovent's Lilly-Partnered Type 2 Diabetes Drug Succeeds in Phase III ...

7/22/2024Gan & Lee Unveils Promising Mid-Stage Data for Homegrown Obesity Drug

7/19/2024ExoNeuglia Secures Investment to Advance Clinical Trials for Neurodege...

7/19/2024Rona Thera Raises $35M Series A+ Financing to Advance Innovative Metab...

7/19/2024Exscientia Acquires Full Control of CDK7 Drug, Plans Breast Cancer Com...

7/19/2024Eli Lilly Wins Label Expansion for Tirzepatide in China

7/19/2024NHSA: DRG Grouping V2.0 to Be Released, Policy Tilt Towards Innovative...

7/19/2024CDE Solicits Public Comments on the Technical Guidelines for In Vitro ...

7/19/2024Beijing to Build International Pharma Innovation Park

7/19/2024Chinese and Visiting Japanese Top Healthcare Officials Agree to Promot...

7/19/2024Recent Executive Moves

7/19/2024Experts Predict Novo Victory in Grueling Chinese Patent Case (MedWatcj...

7/18/2024NMPA Solicits Public Comments on Drafts of the 'GMP for Pharmaceutical...

7/18/2024NMPA Suspends Import, Sales and Use of Daiwoong's Cefodizime Sodium fo...

7/18/2024India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...

7/18/2024Marinus's Ganaxolone Approved in China as First Treatment for Seizures...

7/18/2024Merck Unveils GMP-Compliant Cell Culture Media Manufacturing Line in C...

7/18/2024China Sets Up National Working Group to Standardize Healthcare Securit...

7/17/2024Full-Life Tech, SK Biopharma Enter Licensing Deal for Novel Therapeuti...

7/17/2024SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to E...

7/17/2024Green Cross Sells Hong Kong Unit to China Resources Boya Bio

7/17/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...

7/17/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...

7/17/2024CDE Issues the Technical Guidelines for Clinical Trials of Drugs for G...

7/16/2024NMPA Announces Package Insert Revision of Spleen Polypeptide Injection...

7/16/2024U.S. Senators Introduce Bill to Reduce U.S. Dependence on China for Ph...

7/16/2024Who Will Acquire Legend Bio for 13B to 15B USD? Could It Be J&J? (Drug...

7/16/2024China's Health Supplements Market: Trends and Opportunities for Busine...

7/15/2024China's Fast-following Approach Positions It at the Forefront of the F...

7/15/2024China Biopharma Tracker – H1/2024 (PharmaNJ)

Page:72/790 Total number of articles:23678: [First][<<] [70] [71] [72] [73] [74] [>>] [End]